Wang-Wei Guo

407 total citations
10 papers, 350 citations indexed

About

Wang-Wei Guo is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Wang-Wei Guo has authored 10 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Wang-Wei Guo's work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Wang-Wei Guo is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Wang-Wei Guo collaborates with scholars based in China and Canada. Wang-Wei Guo's co-authors include Min Han, Jianqing Gao, Jiejian Chen, Mengting Lin, Qichun Wei, Ningning Guo, Ming-Yi Huang-Fu, Wenhong Xu, Huina Liu and Afsaneh Lavasanifar and has published in prestigious journals such as ACS Applied Materials & Interfaces, Acta Biomaterialia and Biomacromolecules.

In The Last Decade

Wang-Wei Guo

10 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wang-Wei Guo China	8	197	192	174	41	36	10	350
Ming-Yi Huang-Fu China	8	241 1.2×	233 1.2×	168 1.0×	47 1.1×	28 0.8×	8	398
Shi Du China	5	154 0.8×	204 1.1×	116 0.7×	27 0.7×	35 1.0×	7	307
Chuanyou Guo China	6	192 1.0×	201 1.0×	195 1.1×	32 0.8×	53 1.5×	7	392
Pouya Dehghankelishadi Australia	7	154 0.8×	116 0.6×	131 0.8×	24 0.6×	28 0.8×	14	319
Shunan Wan China	6	199 1.0×	173 0.9×	165 0.9×	31 0.8×	55 1.5×	7	399
Suhuan Dai China	9	162 0.8×	218 1.1×	163 0.9×	28 0.7×	45 1.3×	9	395
Ezgi Özliseli Finland	9	136 0.7×	163 0.8×	123 0.7×	25 0.6×	66 1.8×	14	379
Muhammad Abdur Rahim Pakistan	7	201 1.0×	180 0.9×	150 0.9×	18 0.4×	28 0.8×	9	403
Rujuan Wang China	6	110 0.6×	123 0.6×	159 0.9×	20 0.5×	30 0.8×	6	315

Countries citing papers authored by Wang-Wei Guo

Since Specialization

Citations

This map shows the geographic impact of Wang-Wei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang-Wei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang-Wei Guo more than expected).

Fields of papers citing papers by Wang-Wei Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang-Wei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang-Wei Guo. The network helps show where Wang-Wei Guo may publish in the future.

Co-authorship network of co-authors of Wang-Wei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Wang-Wei Guo. A scholar is included among the top collaborators of Wang-Wei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang-Wei Guo. Wang-Wei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Li, Ying, Jing Luo, Mengting Lin, et al.. (2019). Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment. Molecular Pharmaceutics. 16(7). 2966–2979. 36 indexed citations

Guo, Wang-Wei, Zhentao Zhang, Qichun Wei, et al.. (2019). Intracellular Restructured Reduced Glutathione-Responsive Peptide Nanofibers for Synergetic Tumor Chemotherapy. Biomacromolecules. 21(2). 444–453. 33 indexed citations

Lin, Mengting, Wang-Wei Guo, Zhentao Zhang, et al.. (2019). Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models. Molecular Pharmaceutics. 17(2). 499–506. 8 indexed citations

Xu, Wenhong, Ziting Wang, Wang-Wei Guo, et al.. (2019). Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells. Drug Development and Industrial Pharmacy. 45(9). 1556–1564. 7 indexed citations

Guo, Wang-Wei, Ningning Guo, Ming-Yi Huang-Fu, et al.. (2018). Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy. Acta Biomaterialia. 71. 351–362. 55 indexed citations

Liu, Huina, Ningning Guo, Wang-Wei Guo, et al.. (2018). Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Acta Pharmacologica Sinica. 39(10). 1681–1692. 45 indexed citations

Guo, Ningning, Tiantian Wang, Wang-Wei Guo, et al.. (2018). Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies. Molecular Pharmaceutics. 15(3). 882–891. 60 indexed citations

Han, Min, Ming-Yi Huang-Fu, Wang-Wei Guo, et al.. (2017). MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers via Click Reaction To Enhance Drug Penetration into Solid Tumor. ACS Applied Materials & Interfaces. 9(49). 42459–42470. 100 indexed citations

Han, Min, Chang Li, Wang-Wei Guo, et al.. (2016). [Mitochondrial drug delivery for cancer therapy].. PubMed. 51(2). 257–63. 4 indexed citations

10.

Guo, Wang-Wei, Qi Shen, Ying Wang, et al.. (2012). [Pharmacokinetics of injected cefozopran hydrochloride in healthy volunteers].. PubMed. 43(5). 711–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact